Defective expression of cellular retinol binding protein type 1 and retinoic acid receptors α2, β2, and ǵ2 in human breast cancer cells

Overview of attention for article published in FASEB Journal, July 1996

Altmetric Badge

Mentioned by

patent: 2 patents

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 2 patents that reference this research output.

Therapeutic combinations of RAR antagonists and RXR agonists and use thereof

Grant US-6653322-B1

United States of America

Therapeutic combinations of RAR antagonists and RXR agonists and use thereof

Grant US-6130230-A

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.